Skip to main content
OpenTrials
Completed

NCT Number: NCT05278806

Evaluating the Impact of an Equity Focused Dashboard and Clinical Support

In this project, the impact of providing a practice-level equity dashboard that displays ambulatory quality outcome metrics stratified by race and language to primary care providers at Massachusetts General Hospital (MGH) will be evaluated. Provision of the dashboard data will be paired with additional clinical support focused on hypertension control among Black, Indigenous and People of Color (BIPOC) and patients with limited English proficiency (LEP).

The investigators hypothesize that there will be a improvement in hypertension control (primary outcome), diabetes control and breast cancer screening (secondary outcomes) among Black, Indigenous and People of Color (BIPOC) and patients with limited English proficiency (LEP) in the intervention period compared to the control period.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

About this study

A clinical program will be implemented to utilize the equity dashboard in routine clinical practice augmented by clinical support to address current disparities in hypertension control among MGH primary care patients who are Black, Indigenous and People of Color (BIPOC) as well as patients with limited English proficiency (LEP). The clinical support will be provided by population health coordinators (PHCs) and/or community health workers (CHWs).

To evaluate the program, the investigators propose a stepped wedge design that will randomize the primary care providers to the provision of the equity dashboard and additional clinical support at different intervals. The primary reason to randomize the primary care providers is because the PHCs and CHWs have limited capacity to contact and assist the patients in our primary care practices with poorly controlled hypertension and can only engage a limited number of patients at a time.

The stepped wedge cluster-randomized study design will randomize providers in all 15 MGH primary care practices to receiving the intervention (i.e. equity dashboard with additional clinical support) in twelve groups. Each step will be a one-month period. Providers randomized to Group 1 will receive the equity dashboard data as well as additional clinical support starting in Step 1 while providers randomized to Group 12 will receive the same intervention at the beginning of Step 12 but receive usual care in Steps 0-11. We will match Providers in the opposite steps (e.g. Group 1 vs. Group 12, Group 2 vs. Group 11, etc.) by practice, baseline hypertension control rate, and the number of patients in their panel who are eligible for the intervention to ensure balance between data collected from the intervention periods and control periods. The stepped wedge design will allow for an open cohort (i.e. new patients of the providers allocated to the intervention can enter in subsequent steps) and a repeated measures data analysis with the same patients experiencing both control and intervention conditions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

<Provider Eligibility>

Inclusion criteria

  • Massachusetts General Hospital primary care physician

Exclusion criteria

  • Practice leaders and equity steering committee members as they will all get access to the equity dashboard data.

<Patient Eligibility>

Inclusion criteria

  • Uncontrolled Hypertension AND Black, Indigenous and People of Color (BIPOC) patients or Limited English proficiency (LEP).

Exclusion criteria

  • Not deemed appropriate for intervention by their primary care provider due to terminal illness, advanced dementia, etc.

Treatment and study plan

Equity Dashboard, Population Health Coordinator and Community Health Worker Support

Other

Providers will be given access to an equity dashboard that displays their practice's performance on ambulatory quality metrics stratified by race and language.

Population health coordinators (PHCs) will lead equity huddles with providers to review list of patients who are not at goal for their hypertension control and meet the inclusion criteria. Providers will formulate a follow up plan for each patient that the PHCs will help implement. For example, PHCs may contact patient via the online patient portal or phone to obtain recent home blood pressure readings, facilitate scheduling of follow up visits, etc.

In addition, patients may be referred to the community health worker (CHW) hypertension management program. Patients will work with the CHW for 3-6 months. During this time the CHW will focus their efforts on patient education/coaching, remote blood pressure monitoring, addressing psychosocial and socioeconomic barriers to care and care coordination.

Equity Dashboard and Population Health Coordinator Support

Other

Providers will be given access to an equity dashboard that displays their practice's performance on ambulatory quality metrics stratified by race and language.

In addition, population health coordinators (PHCs) will lead disparities focused huddles with providers. During the huddle, they will review list of patients who are not at goal for their hypertension control and meet the inclusion criteria. Providers will then formulate a follow up plan for each patient that the Population Health Coordinators will help implement. For example, PHCs may contact patient via the online patient portal or phone to obtain recent home blood pressure readings, facilitate scheduling of follow up visits, etc.

Primary outcomes

  1. Hypertension control

    Time frame: 1 year

    • Blood pressure (BP) measured in the last 12 months AND last BP or average of last three BP readings (in the last 18 months) <130/80 or
    • BP measured within past 6 months AND either the last or average of last three BP readings (in the last 18 months) meet one of the following criteria:
    • Age < 60, BP ≤ 140/90
    • Age ≥ 60 with Diabetes, BP ≤ 140/90; without Diabetes, BP ≤ 150/90
    • Age ≥ 60, Diastolic BP < 70, regardless of Systolic
    • On three or more anti-hypertensive medications from three different classes

Secondary outcomes

  1. Hemoglobin A1c control

    Time frame: 1 year

    • Most recent HbA1C in the last 12 months was <7.0% OR
    • Most recent HbA1C within the last 6 months was ≤ 9.0%
  2. Breast cancer screening rates

    Time frame: 1 year

    Completed a mammogram in the past 2 years

Sponsors and collaborators

Lead sponsor

Massachusetts General Hospital

Other

Registry information

Official study title

Evaluating the Impact of an Equity Focused Dashboard and Clinical Support on Disparities in Primary Care Ambulatory Quality Outcome Measures: a Quality Improvement Research Project

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Mar 14, 2022
Registry last updated
Jun 26, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.